MD
Mitaben Dineshbhai Vakil
About Mitaben Dineshbhai Vakil
Data last updated:
Mitaben Dineshbhai Vakil is a Director at Gliesse Pharmaceuticals Private Limited (since 2024). The company operates in Pharma. Gliesse Pharmaceuticals Private Limited reported revenue of ₹6.78 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Gliesse Pharmaceuticals Private Limited U24110GJ2020PTC115404 | Director | 01 Jan 2024 | 2020 | ₹6.78 Cr (FY 2025) | Active |
Board colleagues of Mitaben Dineshbhai Vakil
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jatinbhai Siddharthbhai Shah | 02742285 | Gliesse Pharmaceuticals Private Limited | Director |
| Neel Hetal Shah | 07014036 | Gliesse Pharmaceuticals Private Limited | Director |
| Ruchi Darshan Shah | 02526139 | Gliesse Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mitaben Dineshbhai Vakil
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mitaben Dineshbhai Vakil
Mitaben Dineshbhai Vakil currently holds 1 directorship: Gliesse Pharmaceuticals Private Limited (Director, since 01 Jan 2024, revenue ₹6.78 Cr (FY 2025)).
Mitaben Dineshbhai Vakil was first appointed on 01 Jan 2024 as Director at Gliesse Pharmaceuticals Private Limited.
The current boards of Mitaben Dineshbhai Vakil's companies include Jatinbhai Siddharthbhai Shah (Gliesse Pharmaceuticals Private Limited), Neel Hetal Shah (Gliesse Pharmaceuticals Private Limited), Ruchi Darshan Shah (Gliesse Pharmaceuticals Private Limited).